Page 91 - GTM-2-4

Global Translational Medicine Prognosis of relapse in squamous cell lung cancer

review. Int J Clin Exp Pathol, 7: 3632–3646. for assessment of therapy response in non-small cell lung
cancer: A systematic review and meta-analysis. Br J Cancer,
16. Zissimopoulos A, Stellos K, Permenopoulou V, et al., 2007,
The importance of the tumor marker CYFRA 21–1 in 116: 1037–1045.
patients with lung cancer after surgery or chemotherapy. https://doi.org/10.1038/bjc.2017.45
Hell J Nucl Med, 10: 62–66.
25. Takeuchi S, Nonaka M, Kadokura M, et al., 2003, Prognostic
17. Yeh JJ, Liu FY, Hsu WH, et al., 2002, Monitoring cytokeratin significance of serum squamous cell carcinoma antigen in
fragment 19 (CYFRA 21–1) serum levels for early surgically treated lung cancer. Ann Thorac Cardiovasc Surg,
prediction of recurrence of adenocarcinoma and squamous 9: 98–104. https://pubmed.ncbi.nlm.nih.gov/12732086
cell carcinoma in the lung after surgical resection. Lung, 26. Chen IH, Liao CT, Wang HM, et al., 2014, Using SCC antigen
180: 273–279.
and CRP levels as prognostic biomarkers in recurrent oral
https://doi.org/10.1007/s004080000101 cavity squamous cell carcinoma. PLoS One, 9: e103265.
18. Sawabata N, Maeda H, Yokota S, et al., 2004, Postoperative https://doi.org/10.1371/journal.pone.0103265
serum carcinoembryonic antigen levels in patients 27. Choi KH, Lee SW, Yu M, et al., 2019, Significance of elevated
with pathologic stage IA nonsmall cell lung carcinoma: SCC-Ag level on tumor recurrence and patient survival
Subnormal levels as an indicator of favorable prognosis.
Cancer, 101: 803–809. in patients with squamous-cell carcinoma of uterine
cervix following definitive chemoradiotherapy: A multi-
https://doi.org/10.1002/cncr.20421 institutional analysis. J Gynecol Oncol, 30: e1.
19. Ozeki N, Fukui T, Taniguchi T, et al., 2014, Significance https://doi.org/10.3802/jgo.2019.30.e1
of the serum carcinoembryonic antigen level during the
follow-up of patients with completely resected non-small- 28. Deng Z, Hasegawa M, Yamashita Y, et al., 2012, Prognostic
cell lung cancer. Eur J Cardiothorac Surg, 45: 687–692. value of human papillomavirus and squamous cell carcinoma
antigen in head and neck squamous cell carcinoma. Cancer
https://doi.org/10.1093/ejcts/ezt424 Sci, 103: 2127–2134.
20. Duan X, Cui Y, Li H, et al., 2015, High preoperative and https://doi.org/10.1111/cas.12009
postoperative levels of carcinoembryonic antigen and
CYFRA 21–1 indicate poor prognosis in patients with 29. Bresalier RS, Grady WM, Markowitz SD, et al., 2020,
pathological Stage I nonsmall cell lung cancer. Indian J Biomarkers for Early Detection of colorectal cancer: The
Cancer, 52: E158–E163. early detection research network, a framework for clinical
translation. Cancer Epidemiol Biomarkers Prev, 29: 2431–2440.
https://doi.org/10.4103/0019-509X.186564
https://doi.org/10.1158/1055-9965.EPI-20-0234
21. Barak V, Holdenrieder S, Nisman B, et al., 2010, Relevance
of circulating biomarkers for the therapy monitoring and 30. Sjoberg DD, Vickers AJ, Assel M, et al., 2018, Twenty-year risk
follow-up investigations in patients with non-small cell lung of prostate cancer death by midlife prostate-specific antigen
cancer. Cancer Biomark, 6: 191–196. and a panel of four kallikrein markers in a large population-
based cohort of healthy men. Eur Urol, 73: 941–948.
https://doi.org/10.3233/CBM-2009-0129
https://doi.org/10.1016/j.eururo.2018.02.016
22. Muley T, He Y, Rolny V, et al., 2019, Potential for the
blood-based biomarkers cytokeratin 19 fragment (CYFRA 31. Monroy-Iglesias MJ, Crescioli S, Beckmann K, et al., 2022,
21–1) and human epididymal protein 4 (HE4) to detect Antibodies as biomarkers for cancer risk: A systematic
recurrence during monitoring after surgical resection of review. Clin Exp Immunol, 209: 46–63.
adenocarcinoma of the lung. Lung Cancer, 130: 194–200. https://doi.org/10.1093/cei/uxac030
https://doi.org/10.1016/j.lungcan.2019.02.017 32. Blanco-Prieto S, De Chiara L, Rodríguez-Girondo M, et al.,
2017, Highly Sensitive Marker Panel for Guidance in Lung
23. Pang L, Wang J, Jiang Y, et al., 2013, Decreased levels of
serum cytokeratin 19 fragment CYFRA 21–1 predict Cancer Rapid Diagnostic Units. Sci Rep, 7: 41151.
objective response to chemotherapy in patients with non- https://doi.org/10.1038/srep41151
small cell lung cancer. Exp Ther Med, 6: 355–360.
33. Fahrmann JF, Marsh T, Irajizad E, et al., 2022, Blood-
https://doi.org/10.3892/etm.2013.1171 Based Biomarker Panel for Personalized Lung Cancer Risk
Assessment. J Clin Oncol, 40: 876–883.
24. Holdenrieder S, Wehnl B, Hettwer K, et al., 2017,
Carcinoembryonic antigen and cytokeratin-19 fragments https://doi.org/10.1200/JCO.21.01460

Volume 2 Issue 4 (2023) 12 https://doi.org/10.36922/gtm.2209